87977815 - NANOSTRING

Information

• Trademark
• 87977815

• Source

• Serial Number

  87977815

• Registration Number

  5537412

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  March 28, 2017
  7 years ago

• Registration Date

  August 07, 2018
  6 years ago

• Transaction Date

  July 05, 2024
  6 months ago

• Status Date

  August 07, 2018
  6 years ago

• Published for Opposition Date

  August 22, 2017
  7 years ago

• Location Date

  June 29, 2018
  6 years ago

• First Use Anywhere Date

  January 30, 2018
  6 years ago

• First Use In Commerce Date

  January 30, 2018
  6 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  PAPALE, LISA ANNE

• Attorney Docket Number

  31353-TM1038

  Attorney Name

  Alyssa Worsham

  Law Office Assigned Location Code

  N40

• Owners

  • NANOSTRING TECHNOLOGIES, INC

Case File Statements

• DM0000: The mark consists of the word "nanoString" with a line below the word containing circles.
• GS0051: Diagnostic reagents for medical use in the field of cancer; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogens, comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit and instructional manuals therefor; medical diagnostic kits comprising medical diagnostic reagents for use in detecting the presence of analytes in samples and identifying sample type, and equipment, namely, medical diagnostic immuno-assays for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; replacement parts for medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type in the nature of equipment, namely, medical diagnostic immune-assays for screening samples detecting the presence of analytes in samples and identifying sample type; medical diagnostic reagents for RNA transcription and microRNA expression profiling, proteomics, small molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for diagnostics for a variety of uses in health care namely, medical diagnostic reagents for RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; tests designed to isolate and extract cells for genetic analysis, namely, reagents for medical diagnostic use; medical diagnostic reagents and assays for testing of body fluids; kits consisting primarily of medical diagnostic reagents and assays for testing of body fluids; reagents in the form of cell markers and molecule markers for medical purposes
• CC0000: Color is not claimed as a feature of the mark.
• GS0011: Diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diagnostic test kits for scientific use comprising reagents, slides, solid matrix materials, microfluidic devices and support documentation, namely, instructional manuals, therefor; diagnostic test kits comprising reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory use, namely, reagents for proteomics, RNA transcription and microRNA expression profiling, small- molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectors, namely, reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research uses, namely, RNA transcription profiling, proteomics, clinical diagnostics, environmental monitoring, biosurveillance, agricultural inspection, forensic testing of samples containing microorganisms or human fluids, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; test kits, consisting of chemical preparations for scientific purposes, in particular for the detection, diagnosis, progress monitoring and progress prediction of diseases, including inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers; assays, reagents, enzymes, polymerases, buffers and nucleotides, and kits comprised thereof, all for scientific or research use; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in life science sectors namely, diagnostic reagents for scientific in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small- molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing
• GS0421: Research and product development services for others in the field of biotechnology; medical and scientific research in the field of cancer treatment and diagnosis; providing laboratory research services in the field of gene expression; genetic data mining; providing molecule identification methods for acquiring, analyzing and managing biological and genetic information, in the fields of genetics and environment; research and development services for others in the field of diagnostic compounds for use in medicine, measuring apparatus for use in product research and development, separation and purification processes, environmental and testing processes, and industrial quality control processes; developing systems for acquiring, analyzing, and managing biological and genetic information in the fields of diagnostic reagents, forensics, medicine, genetics, and environment; research, design, and development services for others in the fields of diagnostic reagents, compounds and devices, measuring apparatus for use in product research and development, separation and purification processes, environmental and testing processes and industrial quality control processes; chemical screening analysis for others

Case File Event Statements

• 4/4/2017 - 7 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 3/31/2017 - 7 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 4/1/2017 - 7 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 6/20/2017 - 7 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 6/22/2017 - 7 years ago

  5 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 6/22/2017 - 7 years ago

  8 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 6/22/2017 - 7 years ago

  7 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 6/22/2017 - 7 years ago

  6 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 6/23/2017 - 7 years ago

  9 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 8/2/2017 - 7 years ago

  10 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 8/22/2017 - 7 years ago

  11 - PUBLISHED FOR OPPOSITION Type: PUBO

• 8/22/2017 - 7 years ago

  12 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 10/17/2017 - 7 years ago

  13 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 3/30/2018 - 6 years ago

  14 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 3/30/2018 - 6 years ago

  15 - SOU EXTENSION 1 FILED Type: EXT1

• 3/30/2018 - 6 years ago

  16 - SOU EXTENSION 1 GRANTED Type: EX1G

• 4/3/2018 - 6 years ago

  17 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 6/4/2018 - 6 years ago

  18 - TEAS STATEMENT OF USE RECEIVED Type: EISU

• 6/4/2018 - 6 years ago

  19 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD

• 6/4/2018 - 6 years ago

  21 - DIVISIONAL REQUEST RECEIVED Type: DRRR

• 6/8/2018 - 6 years ago

  20 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 6/8/2018 - 6 years ago

  22 - DIVISIONAL PROCESSING COMPLETE Type: DPCC

• 6/4/2018 - 6 years ago

  23 - USE AMENDMENT FILED Type: IUAF

• 6/8/2018 - 6 years ago

  24 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC

• 6/9/2018 - 6 years ago

  25 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 6/29/2018 - 6 years ago

  26 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR

• 6/30/2018 - 6 years ago

  27 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA

• 8/7/2018 - 6 years ago

  28 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 3/18/2020 - 4 years ago

  29 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK

• 8/7/2023 - a year ago

  30 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1

• 6/3/2024 - 7 months ago

  31 - TEAS SECTION 8 & 15 RECEIVED Type: E815

• 7/4/2024 - 6 months ago

  32 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN